Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 108
Filtrar
1.
Sci Rep ; 11(1): 10248, 2021 05 13.
Artigo em Inglês | MEDLINE | ID: mdl-33986309

RESUMO

Vascular contributions to cognitive impairment and dementia (VCID) include structural and functional blood vessel injuries linked to poor neurocognitive outcomes. Smoking might indirectly increase the likelihood of cognitive impairment by exacerbating vascular disease risks. Sex disparities in VCID have been reported, however, few studies have assessed the sex-specific relationships between smoking and memory performance and with contradictory results. We investigated the associations between sex, smoking, and cardiovascular disease with verbal learning and memory function. Using MindCrowd, an observational web-based cohort of ~ 70,000 people aged 18-85, we investigated whether sex modifies the relationship between smoking and cardiovascular disease with verbal memory performance. We found significant interactions in that smoking is associated with verbal learning performance more in women and cardiovascular disease more in men across a wide age range. These results suggest that smoking and cardiovascular disease may impact verbal learning and memory throughout adulthood differently for men and women.


Assuntos
Fumar Cigarros/efeitos adversos , Memória/efeitos dos fármacos , Aprendizagem Verbal/efeitos dos fármacos , Adulto , Idoso , Idoso de 80 Anos ou mais , Fumar Cigarros/psicologia , Cognição/efeitos dos fármacos , Cognição/fisiologia , Disfunção Cognitiva/fisiopatologia , Estudos de Coortes , Demência Vascular/etiologia , Feminino , Humanos , Masculino , Memória/fisiologia , Pessoa de Meia-Idade , Fatores Sexuais , Aprendizagem Verbal/fisiologia
2.
Psychopharmacology (Berl) ; 236(12): 3439-3450, 2019 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-31250074

RESUMO

RATIONALE: Cannabis use is widespread and has previously been associated with memory impairments. However, the role of cannabis in relation to false memory production, i.e., memories of events that were not experienced, is less well-understood. OBJECTIVE: The aim of the current field study was to examine the impact of cannabis use on false memory production. METHODS: The Deese/Roediger-McDermott (DRM) paradigm was used to induce false memories. In this paradigm, participants study word lists that are associatively related to a non-presented word, termed the critical lure. In a later memory test, true recognition rates and false alarm rates toward critical lures and unrelated items are assessed. Memory performance was compared between three groups: regular cannabis consumers who were acutely intoxicated (n = 53), regular cannabis consumers who were sober (n = 50), and cannabis-naïve controls (n = 53). The participants were approached in Dutch coffee shops (cannabis outlets) and cafes and asked to participate in our study. After collecting general information on their cannabis use, they were subjected to the DRM procedure. RESULTS: Although false memory rates for critical lures did not statistically differ between groups, both intoxicated and sober cannabis consumers falsely recognized more unrelated items than control participants. Also, individuals without a history of cannabis use demonstrated higher memory accuracy compared with the intoxicated group. CONCLUSION: It is concluded that cannabis intoxication and history of cannabis use induce a liberal response criterion for newly presented words for which the level of association with previously learned words is low and uncertainty is high.


Assuntos
Fumar Maconha/efeitos adversos , Fumar Maconha/psicologia , Transtornos da Memória/induzido quimicamente , Transtornos da Memória/psicologia , Memória/efeitos dos fármacos , Repressão Psicológica , Adolescente , Adulto , Cognição/efeitos dos fármacos , Cognição/fisiologia , Feminino , Humanos , Masculino , Memória/fisiologia , Rememoração Mental/efeitos dos fármacos , Rememoração Mental/fisiologia , Aprendizagem Verbal/efeitos dos fármacos , Aprendizagem Verbal/fisiologia , Adulto Jovem
3.
J Psychopharmacol ; 33(7): 801-810, 2019 07.
Artigo em Inglês | MEDLINE | ID: mdl-31169441

RESUMO

BACKGROUND: Little is known about the functional status of older drug users, who may pose challenges to public health systems in coming years. Here, we assessed cognitive function in aging cocaine smokers compared to demographically matched controls. METHODS: A total of 22 non-treatment-seeking aging (50-60 years old) cocaine smokers (⩾twice/week; ⩾15 years of weekly use) and 19 controls completed a comprehensive cognitive battery. Controls with cannabis, tobacco, and alcohol use were included to better match the cocaine users. All cocaine users, and current cannabis- or alcohol-using controls, completed testing after 4 drug-free inpatient days to better control for acute and residual drug effects. RESULTS: Cocaine users (52.9 ± 2.5 years old, four female; cocaine use 3.9 ± 1.4 days/week) and controls (52.7 ± 2.6 years old, four female) were well matched demographically, but cocaine users reported a more extensive substance use profile. Cocaine users showed marginally worse verbal learning than controls, recalling on average one word fewer across immediate and delayed word recall trials. Their performance was intact relative to controls across all other measures of cognitive function. Bayesian analysis indicated the absence of group differences was not due to power limitations. CONCLUSION: These data suggest that aging, long-term cocaine users have similar cognitive functioning to appropriately matched controls when tested under drug-free conditions, with only marginal decreases in verbal learning. Findings, although reassuring with regard to broad cognitive capacities in aging cocaine smokers, suggest that future investigations of cognitive function in aging drug users are warranted.


Assuntos
Transtornos Relacionados ao Uso de Cocaína/complicações , Transtornos Cognitivos/epidemiologia , Cognição/efeitos dos fármacos , Aprendizagem Verbal/efeitos dos fármacos , Consumo de Bebidas Alcoólicas/efeitos adversos , Transtornos Cognitivos/etiologia , Usuários de Drogas , Feminino , Humanos , Masculino , Abuso de Maconha/complicações , Pessoa de Meia-Idade , Testes Neuropsicológicos , Uso de Tabaco/efeitos adversos
4.
Rev. méd. Chile ; 147(2): 206-211, Feb. 2019. tab
Artigo em Inglês | LILACS | ID: biblio-1043153

RESUMO

ABSTRACT Background: There is concern about the cognitive consequences of marijuana consumption. Aim: To assess the influence of current and past marijuana use and frequency on verbal learning and memory in a sample of adults aged 21 years old. Material and Methods: Marijuana use was assessed using a clinician administered interview in 654 participants (56% females), who reported frequency of use, age of first use and whether its use led to problems in their lives. The CogState International Shopping List was administered to assess learning and memory. Results: Seventy percent reported ever using marijuana, 46% consuming during the past year and 27% during the past 30 days. The latter scored significantly lower on delayed recall. Current and frequent use were significantly associated with lower accuracy in verbal learning and memory. Conclusions: In this cohort of adults aged 21 years old, marijuana use was prevalent and related to worse verbal memory.


Antecedentes: Existe preocupación acerca de los efectos cognitivos del consumo de marihuana. Objetivo: Estudiar el efecto de consumo de marihuana presente o pasado en la capacidad de aprendizaje verbal y memoria en una muestra de adultos de 21 años. Material y Métodos: El consumo de marihuana fue evaluado mediante una entrevista médica en 654 adultos de 21 años (56% mujeres), quienes informaron acerca de la frecuencia de consumo, edad de comienzo y si el consumo les ha causado problemas en sus vidas. Se les administró el Cogstate International Shopping List para evaluar aprendizaje y memoria. Resultados: El 70% informó haber consumido marihuana alguna vez, 46% la usó durante el último año y el 27% en los últimos 30 días. Estos últimos tuvieron un menor puntaje en memoria tardía. El consumo actual y frecuente se asoció a una menor precisión en la capacidad de aprendizaje verbal y memoria. Conclusiones: En esta cohorte de adultos de 21 años, el consumo de marihuana fue prevalente y relacionado a una menor memoria verbal.


Assuntos
Humanos , Masculino , Feminino , Adulto Jovem , Rememoração Mental/efeitos dos fármacos , Aprendizagem Verbal/efeitos dos fármacos , Canabinoides/farmacologia , Uso da Maconha/epidemiologia , Memória/efeitos dos fármacos , Fatores de Tempo , Chile/epidemiologia , Abuso de Maconha/etiologia , Abuso de Maconha/epidemiologia , Estudos Transversais , Transtornos Cognitivos/complicações , Uso da Maconha/efeitos adversos , Testes Neuropsicológicos
5.
Hum Psychopharmacol ; 33(2): e2649, 2018 03.
Artigo em Inglês | MEDLINE | ID: mdl-29363182

RESUMO

The highest incidence of relapse to smoking occurs within the first 2 weeks of a cessation attempt. In addition to enhanced nicotine craving, this phase of smoking cessation is also marked by learning and memory dysfunction. Many smokers are not able to overcome these symptoms, and they relapse to smoking shortly after trying to quit. In two clinical studies, we evaluated intranasal insulin for efficacy in improving learning and memory function during nicotine withdrawal. Our first study was a crossover evaluation (N = 19) following 20 hr of smoking abstinence. Study 2 was a parallel design study (N = 50) following 16 hr of abstinence. Intranasal insulin (60 IU) dose was administered in both studies and cognitive function was measured using California Verbal Learning Test-II. Intranasal insulin did not improve learning over the 5 verbal learning trials. In addition, intranasal insulin did not improve either short- or long-delay recall in either study. In summary, the one-time administration of intranasal insulin does not improve verbal learning and memory in smokers. Whether longer administration schedules may be of benefit should be evaluated in future studies.


Assuntos
Abstinência de Álcool , Hipoglicemiantes/administração & dosagem , Insulina/administração & dosagem , Deficiências da Aprendizagem/etiologia , Tabagismo/complicações , Tabagismo/tratamento farmacológico , Adolescente , Adulto , Idoso , Feminino , Humanos , Injeções Intramusculares/métodos , Masculino , Pessoa de Meia-Idade , Testes Neuropsicológicos , Aprendizagem Verbal/efeitos dos fármacos , Adulto Jovem
6.
Breast Cancer Res Treat ; 168(2): 299-310, 2018 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-29264751

RESUMO

PURPOSE: Evidence suggests anti-estrogen endocrine therapy (ET) is associated with adverse cognitive effects; however, findings are based on small samples and vary in the cognitive abilities affected. We conducted a meta-analysis to quantitatively synthesize the evidence. METHODS: Electronic databases were searched in November 2016. Fourteen studies totaling 911 BC patients on aromatase inhibitors (AIs) or tamoxifen (TAM) and 911 controls (i.e., non-cancer controls and BC controls not using ET) were included. Neuropsychological tests were categorized into six domains. Effect sizes were computed to compare (1) ET patients versus controls and (2) TAM patients versus AI patients. RESULTS: In cross-sectional comparisons, ET patients performed worse than control groups on verbal learning/memory, visual learning/memory, frontal executive function, and processing speed, but did not differ on psychomotor efficiency or visuospatial function. Subgroup analyses revealed that verbal learning/memory was the only domain where ET patients performed worse than both non-cancer and BC controls. In other domains, ET patients and BC controls performed equivalently. Regarding change from pre-treatment performance, ET patients did not differ from controls on any domain. TAM and AI patients did not from one another differ overall; however, subgroup analyses indicated that TAM patients performed better than non-steroidal AI patients on several domains, but showed few performance differences relative to steroidal AI patients. CONCLUSIONS: Verbal learning/memory was the only domain where ET patients performed worse than both non-cancer and BC controls, suggesting specific adverse effects on this domain. Additional studies assessing change from pre-treatment performance and differences between steroidal and non-steroidal AIs are warranted.


Assuntos
Antineoplásicos Hormonais/efeitos adversos , Inibidores da Aromatase/efeitos adversos , Neoplasias da Mama/tratamento farmacológico , Transtornos Cognitivos/induzido quimicamente , Cognição/efeitos dos fármacos , Transtornos Cognitivos/diagnóstico , Estudos Transversais , Feminino , Humanos , Memória/efeitos dos fármacos , Testes Neuropsicológicos , Aprendizagem Verbal/efeitos dos fármacos
7.
J Clin Exp Neuropsychol ; 40(6): 529-543, 2018 08.
Artigo em Inglês | MEDLINE | ID: mdl-29058519

RESUMO

INTRODUCTION: Adolescent cannabis use (CU) is associated with impaired attention, executive function, and verbal learning/memory. These associations are generally observed in cross-sectional studies. Longitudinal studies of cannabis users are lacking. METHOD: The present study examines associations between CU and cognition over time in chronic daily adolescent-onset CUs, as compared to nonusing controls. Both groups completed a neuropsychological battery at study intake and again 2 years later. RESULTS: Baseline group differences have been published and indicated deficits in verbal learning and memory, motivated decision-making, planning, and working memory in CUs. In this follow-up report, the longitudinal performance of users is compared to that of sustained nonusers using the same battery. At follow-up, the majority of CUs continued to report regular and heavy cannabis use. Relative impairments in the domains of working memory, planning and verbal memory remained stable, suggesting that these are enduring vulnerabilities associated with continued CU during young adulthood. Improvements in motivated decision-making were evident in both groups. In addition, CUs demonstrated relatively better performance on short-duration speeded tasks. An earlier age of CU onset was associated with poorer verbal learning and memory and planning performance over time. CONCLUSIONS: Verbal learning and memory and planning processes, as well as their neural correlates, merit further scrutiny within etiological models of cannabis-induced cognitive impairments.


Assuntos
Cognição/efeitos dos fármacos , Abuso de Maconha/psicologia , Fumar Maconha/psicologia , Atenção/efeitos dos fármacos , Tomada de Decisões/efeitos dos fármacos , Função Executiva , Feminino , Jogo de Azar/psicologia , Humanos , Estudos Longitudinais , Masculino , Transtornos da Memória/induzido quimicamente , Transtornos da Memória/psicologia , Memória de Curto Prazo/efeitos dos fármacos , Motivação/efeitos dos fármacos , Testes Neuropsicológicos , Desempenho Psicomotor/efeitos dos fármacos , Aprendizagem Verbal/efeitos dos fármacos , Adulto Jovem
8.
Neurotoxicology ; 63: 106-119, 2017 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-28947237

RESUMO

In the context of a health surveillance program for former PCB-exposed workers of a transformer and capacitor recycling company in Germany, their family members, employees of surrounding companies and area residents a broad range of cognitive functions covering attention, executive processing, reasoning, memory and motor performance was examined. The study aimed at identifying potential adverse effects of PCB load on cognitive functions. Detailed analysis of PCB burden of the participants revealed rather high correlations of lower and higher chlorinated as well as dioxin-like PCBs. Nearly one half of the participants exhibited increased burden in all three PCB classes whereas only 33 out of 237 participants did not show any increased PCB burden. Thus, data analysis followed a two-fold strategy: (1) Based on studies providing data on PCB exposure of the German general population the PCB burden of every participant was classified as normal (percentile rank PR <95) or increased (PR ≥95). Increased burden with respect to lower (LPCBs) and higher chlorinated (HPCBs) as well as dioxin-like (dlPCBs) PCBs was assumed if a participant showed at least one congener surpassing the PR95 criterion for the respective congener class and (2) Overall plasma PCB level per congener class was used as measure of PCB load. In a multivariate approach using structural equation modelling and multiple regression analysis we found a significant impact of PCBs on word fluency and sensorimotor processing irrespective of the measure of PCB burden (PR95 criterion or overall plasma level). However, no effect of PCB burden on memory, attention, and cognitive flexibility could be demonstrated. Particularly, an increase of LPCBs was associated with an overall reduction of verbal fluency of letter and semantic word generation as well as word production based on a single or two alternating criteria. In addition, participants with increased burden of LPCBs exhibited a time-on-task effect in terms of a stronger decline of performance with increasing duration of the verbal fluency task. Moreover, we found adverse effects of HPCBs on Aiming and of dlPCBs on Line Tracking. Results are discussed in terms of (1) a decrease of cerebral dopamine (DA) with non-coplanar PCBs resulting in an impact on fronto-striatal cerebral structures subserving verbal fluency and motor processing, (2) a PCB-induced reduction of norepinephrine leading to the time-on-task effect with verbal fluency, and (3) adverse effects of PCBs on dopaminergic receptors in the cerebellum resulting in impaired fine motor function.


Assuntos
Cognição/efeitos dos fármacos , Poluentes Ambientais/efeitos adversos , Bifenilos Policlorados/efeitos adversos , Adulto , Idoso , Idoso de 80 Anos ou mais , Transtorno do Deficit de Atenção com Hiperatividade/induzido quimicamente , Transtorno do Deficit de Atenção com Hiperatividade/diagnóstico , Poluentes Ambientais/sangue , Feminino , Alemanha , Humanos , Inteligência/efeitos dos fármacos , Masculino , Memória/efeitos dos fármacos , Pessoa de Meia-Idade , Testes Neuropsicológicos , Bifenilos Policlorados/sangue , Desempenho Psicomotor/efeitos dos fármacos , Análise de Regressão , Percepção Espacial/efeitos dos fármacos , Aprendizagem Verbal/efeitos dos fármacos , Adulto Jovem
9.
Nutr Hosp ; 34(2): 352-356, 2017 03 30.
Artigo em Espanhol | MEDLINE | ID: mdl-28421789

RESUMO

Introduction: Alzheimer's disease is one of the most prevalent neurodegenerative dementia in developed world. This fact, coupled with the lack cure, makes new no pharmacological therapeutic strategies such as nutrient management to investigate. In this regard, it stresses the possible influence of coconut oil as alternative energy source capable of stopping the progressively neuronal death that occurs in this disease. Objectives: To assess the cognitive impact of coconut oil in Alzheimer's patients, and specifically in orientation, language-building, fixing, calculation-concentration and memory areas. Methods: Prospective, longitudinal, qualitative, analytical and experimental study through a clinical trial where 44 patients with Alzheimer's in region of Ribera (Valencia), of which half was selected to receive during 21 days, 40 ml coconut oil daily divided between breakfast (20 ml) and food (20 ml). Before and after administration of the oil, they were evaluated through cognitive test Mini-Mental State Examination to determine possible changes. Results: It was observed in patients who received coconut oil, that cognitive improvement after completion of the intervention, statistically significant improved in the orientation and language-construction areas. Conclusions: Coconut oil appears to improve cognitive abilities of Alzheimer's patients, with different intensity depending on the cognitive area.


Introducción: la enfermedad de Alzheimer es a día de hoy la demencia neurodegenerativa con mayor prevalencia en el primer mundo. Este hecho, unido a la falta de tratamiento farmacológico que cure la enfermedad, hace que se estudien nuevas estrategias terapéuticas no farmacológicas como es la administración de nutrientes. En este sentido, destaca la posible influencia del aceite de coco como fuente energética alternativa, capaz de frenar la muerte neuronal que se produce de modo progresivo en esta enfermedad. Objetivos: valorar el impacto del aceite de coco a nivel cognitivo en pacientes de alzhéimer, y concretamente en las áreas de orientación, lenguaje-construcción, fijación, cálculo-concentración y memoria. Métodos: estudio prospectivo, longitudinal, cualitativo, analítico y experimental a través de un ensayo clínico, donde se seleccionaron a 44 pacientes con alzhéimer de la zona de la Ribera (Comunidad Valenciana), de los cuales a la mitad se le administró durante 21 días, 40 ml diarios de aceite de coco repartidos entre desayuno (20 ml) y comida (20 ml). Antes y después de la administración del aceite, se les valoró a través del test cognitivo Mini-Examen Cognoscitivo, para determinar los posibles cambios. Resultados: en los enfermos que tomaron el aceite de coco se observó una mejora cognitiva tras finalizar la intervención, siendo estadísticamente significativa en las áreas de orientación y lenguaje-construcción. Conclusiones: el aceite de coco parece mejorar la capacidad cognitiva de los enfermos de alzhéimer, variando la intensidad de la misma en función del área cognitiva.


Assuntos
Doença de Alzheimer/tratamento farmacológico , Doença de Alzheimer/psicologia , Óleo de Coco/uso terapêutico , Cognição/efeitos dos fármacos , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Estudos Longitudinais , Masculino , Memória , Orientação/efeitos dos fármacos , Estudos Prospectivos , Desempenho Psicomotor/efeitos dos fármacos , Aprendizagem Verbal/efeitos dos fármacos
10.
Memory ; 25(10): 1327-1339, 2017 11.
Artigo em Inglês | MEDLINE | ID: mdl-28285570

RESUMO

Data from research on amnesia and epilepsy are equivocal with regards to the dissociation, shown in animal models, between rapid and slow long-term memory consolidation. Cancer treatments have lasting disruptive effects on memory and on brain structures associated with memory, but their acute effects on synaptic consolidation are unknown. We investigated the hypothesis that cancer treatment selectively impairs slow synaptic consolidation. Cancer patients and their matched controls were administered a novel list-learning task modelled on the Rey Auditory Verbal Learning Test. Learning, forgetting, and retrieval were tested before, and one day after patients' first chemotherapy treatment. Due to difficulties recruiting cancer patients at that sensitive time, we were only able to study 10 patients and their matched controls. Patients exhibited treatment-dependent accelerated forgetting over 24 hours compared to their own pre-treatment performance and to the performance of control participants, in agreement with our hypothesis. The number of intrusions increased after treatment, suggesting retrieval deficits. Future research with larger samples should adapt our methods to distinguish between consolidation and retrieval causes for treatment-dependent accelerated forgetting. The presence of significant accelerated forgetting in our small sample is indicative of a potentially large acute effect of chemotherapy treatment on forgetting, with potentially clinically relevant implications.


Assuntos
Tratamento Farmacológico/psicologia , Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos/psicologia , Transtornos da Memória/induzido quimicamente , Adolescente , Adulto , Amnésia/induzido quimicamente , Amnésia/complicações , Estudos de Casos e Controles , Feminino , Humanos , Masculino , Rememoração Mental/efeitos dos fármacos , Pessoa de Meia-Idade , Testes Neuropsicológicos , Aprendizagem Verbal/efeitos dos fármacos , Adulto Jovem
11.
Eur Radiol ; 27(7): 2679-2688, 2017 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-27878584

RESUMO

OBJECTIVES: To characterize the pattern of altered intrinsic brain activity in gastric cancer patients after chemotherapy (CTx). METHODS: Patients before and after CTx (n = 14) and control subjects (n = 11) underwent resting-state functional MRI (rsfMRI) at baseline and 3 months after CTx. Regional homogeneity (ReHo), amplitude of low-frequency fluctuation (ALFF), and fractional ALFF (fALFF) were calculated and compared between the groups using the two-sample t test. Correlation analysis was also performed between rsfMRI values (i.e., ReHo, ALFF, and fALFF) and neuropsychological test results. RESULTS: Patients showed poor performance in verbal memory and executive function and decreased rsfMRI values in the frontal areas even before CTx and showed decreased attention/working memory and executive function after CTx compared to the control subjects. In direct comparison of values before and after CTx, there were no significant differences in neuropsychological test scores, but decreased rsfMRI values were observed at the frontal lobes and right cerebellar region. Among rsfMRI values, lower ALFF in the left inferior frontal gyrus was significantly associated with poor performance of the executive function test. CONCLUSIONS: We observed decreased attention/working memory and executive function that corresponded to the decline of frontal region activation in gastric cancer patients who underwent CTx. KEY POINTS: • Intrinsic brain activity of gastric cancer patients after chemotherapy was described. • Brain activity and neuropsychological test results were correlated. • Working memory and executive function decreased after chemotherapy. • Decreased cognitive function corresponded to decreased activation of the frontal region.


Assuntos
Antineoplásicos/efeitos adversos , Encéfalo/fisiopatologia , Neoplasias Gástricas/tratamento farmacológico , Adulto , Análise de Variância , Atenção/efeitos dos fármacos , Atenção/fisiologia , Encéfalo/efeitos dos fármacos , Estudos de Casos e Controles , Cognição/efeitos dos fármacos , Cognição/fisiologia , Função Executiva/efeitos dos fármacos , Função Executiva/fisiologia , Lobo Frontal/fisiopatologia , Humanos , Imageamento por Ressonância Magnética/métodos , Masculino , Pessoa de Meia-Idade , Testes Neuropsicológicos , Estudos Prospectivos , Neoplasias Gástricas/fisiopatologia , Aprendizagem Verbal/efeitos dos fármacos , Aprendizagem Verbal/fisiologia
12.
Drug Alcohol Depend ; 169: 134-140, 2016 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-27810656

RESUMO

BACKGROUND: The relationship between cannabis use and cognitive function in mid-life has rarely been examined despite verbal learning deficits in young adults. METHOD: A longitudinal cohort study of 1,897 Australians recruited at 40-46 years of age and followed up 4 years (94%) and 8 years (87%) later. Random effects regression was used to assess within- and between-person associations between cannabis use and cognitive function across waves of data, and examine whether age-related changes in cognitive performance were modified by cannabis use. The first list of the California Verbal Learning Test (immediate and delayed recall), Symbol Digit Modality Test, Digit Backwards, simple and choice reaction time tasks, were administered at each wave. The Spot-the-Word test was used to assess premorbid verbal ability. Self-reported cannabis use in the past year (no use, < weekly use,≥weekly use) was assessed at each wave. FINDINGS: Participants who used cannabis≥weekly had worse immediate recall (b=-0.68, p=0.014) and showed a trend toward worse delayed recall (b=-0.55, p=0.062) compared to non-users after adjusting for correlates of cannabis use and premorbid verbal ability. These effects were due to between-person differences. There were no significant within-person associations between cannabis use and recall, nor was there evidence of greater cognitive decline in cannabis users with age. CONCLUSIONS: Mid-life cannabis users had poorer verbal recall than non-users, but this was not related to their current level of cannabis use, and cannabis use was not associated with accelerated cognitive decline.


Assuntos
Cognição/efeitos dos fármacos , Fumar Maconha/epidemiologia , Fumar Maconha/psicologia , Memória de Curto Prazo/efeitos dos fármacos , Aprendizagem Verbal/efeitos dos fármacos , Adulto , Austrália/epidemiologia , Cannabis , Cognição/fisiologia , Estudos de Coortes , Feminino , Seguimentos , Humanos , Estudos Longitudinais , Masculino , Abuso de Maconha/epidemiologia , Abuso de Maconha/psicologia , Fumar Maconha/efeitos adversos , Memória de Curto Prazo/fisiologia , Rememoração Mental/efeitos dos fármacos , Rememoração Mental/fisiologia , Pessoa de Meia-Idade , Testes Neuropsicológicos , Distribuição Aleatória , Tempo de Reação/efeitos dos fármacos , Tempo de Reação/fisiologia , Aprendizagem Verbal/fisiologia
13.
Alcohol Clin Exp Res ; 40(9): 1895-904, 2016 09.
Artigo em Inglês | MEDLINE | ID: mdl-27462830

RESUMO

BACKGROUND: Binge drinking has been linked to neurocognitive disadvantages in youth, but it is unclear whether drinking at particularly heavy levels uniquely affects neurocognitive performance. This study prospectively examined (1) whether initiating moderate, binge, or extreme-binge drinking in adolescence differentially influences subsequent learning and memory performances, and (2) whether dosage of alcohol consumption is linearly associated with changes in learning and memory over 6 years of adolescence. METHODS: Participants, who later transitioned into drinking, were administered verbal learning and memory (VLM) assessments at project intake prior to the onset of substance use (age 12 to 16 years), and at follow-up approximately 6 years later (N = 112). Participants were grouped based on alcohol involvement at follow-up as follows: moderate (≤4 drinks per occasion), binge (5+ drinks per occasion), or extreme-binge (10+ drinks per occasion) drinkers. RESULTS: Despite equivalent performances prior to onset of drinking, extreme-binge drinkers performed worse than moderate drinkers on verbal learning, and cued and free short delayed recall (ps < 0.05); binge drinkers did not differ from the other groups. No distinct thresholds in alcohol quantity to differentiate the 3 groups were detected, but estimated peak blood alcohol concentrations were linearly associated with verbal learning (ß^ = -0.24), and immediate (ß^ = -0.27), short delay free (ß^ = -0.28) and cued (ß^ = -0.30), and long delay free (ß^ = -0.24) and cued (ß^ = -0.27) recall (ps < 0.05). CONCLUSIONS: Drinking quantity during adolescence appears to adversely affect VLM in a dose-dependent manner. The acquisition of new verbal information may be particularly affected, notably for those who initiated drinking 10+ drinks in an occasion. Although classification of drinkers into categories remains critical in the study of alcohol, it is important to consider that subtle differences may exist within drinking categories.


Assuntos
Comportamento do Adolescente/fisiologia , Comportamento do Adolescente/psicologia , Consumo de Bebidas Alcoólicas/psicologia , Consumo Excessivo de Bebidas Alcoólicas/psicologia , Memória/fisiologia , Aprendizagem Verbal/fisiologia , Adolescente , Consumo de Bebidas Alcoólicas/sangue , Consumo de Bebidas Alcoólicas/fisiopatologia , Consumo Excessivo de Bebidas Alcoólicas/sangue , Consumo Excessivo de Bebidas Alcoólicas/fisiopatologia , Criança , Etanol/administração & dosagem , Etanol/sangue , Feminino , Seguimentos , Humanos , Masculino , Memória/efeitos dos fármacos , Estudos Prospectivos , Autorrelato , Aprendizagem Verbal/efeitos dos fármacos
14.
Neuropsychology ; 30(4): 405-15, 2016 05.
Artigo em Inglês | MEDLINE | ID: mdl-26986749

RESUMO

OBJECTIVE: Verbal memory difficulties are the most widely reported and persistent cognitive deficit associated with early onset marijuana use. Yet, it is not known what memory stages are most impaired in those with early marijuana use. METHOD: Forty-eight young adults, aged 18-25, who used marijuana at least once per week and 48 matched nonusing controls (CON) completed the California Verbal Learning Test, Second Edition (CVLT-II). Marijuana users were stratified by age of initial use: early onset users (EMJ), who started using marijuana at or before age 16 (n = 27), and late onset marijuana user group (LMJ), who started using marijuana after age 16 (n = 21). Outcome variables included trial immediate recall, total learning, clustering strategies (semantic clustering, serial clustering, ratio of semantic to serial clustering, and total number of strategies used), delayed recall, and percent retention. RESULTS: Learning improved with repetition, with no group effect on the learning slope. EMJ learned fewer words overall than LMJ or CON. There was no difference between LMJ and CON in total number of words learned. Reduced overall learning mediated the effect on reduced delayed recall among EMJ, but not CON or LMJ. Learning improved with greater use of semantic versus serial encoding, but this did not vary between groups. EMJ was not related to delayed recall after adjusting for encoding. CONCLUSIONS: Young adults reporting early onset marijuana use had learning weaknesses, which accounted for the association between early onset marijuana use and delayed recall. No amnestic effect of marijuana use was observed. (PsycINFO Database Record


Assuntos
Cannabis/efeitos adversos , Fumar Maconha/efeitos adversos , Transtornos da Memória/induzido quimicamente , Memória de Curto Prazo/efeitos dos fármacos , Rememoração Mental/efeitos dos fármacos , Aprendizagem Verbal/efeitos dos fármacos , Adolescente , Adulto , Fatores Etários , Feminino , Humanos , Masculino , Adulto Jovem
15.
Am J Psychiatry ; 173(8): 827-35, 2016 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-26940805

RESUMO

OBJECTIVE: The authors sought to evaluate the efficacy and safety of ABT-126, a selective α7 nicotinic receptor partial agonist, in stable patients with schizophrenia. METHOD: A 12-week, double-blind, placebo-controlled, parallel-group phase 2 study was conducted in 22 centers in the United States. Clinically stable patients with schizophrenia were randomly assigned to receive once-daily dosing with 10 mg of ABT-126, 25 mg of ABT-126, or placebo. The primary efficacy measure was change from baseline to week 12 on the MATRICS Consensus Cognitive Battery (MCCB) composite score compared with placebo, tested by a one-sided t test. Secondary measures included MCCB domain scores and UCSD Performance-Based Skills Assessment total score, each tested by two-sided t tests. RESULTS: A total of 207 subjects were randomized, of whom 165 (81%) completed the study. ABT-126 showed an improvement that fell short of significance on the MCCB composite score at week 12 (least squares mean difference from placebo, 1.3 and 1.5 for the 10 mg and 25 mg groups, respectively). A significant treatment-by-smoking status interaction was observed on the mean change from baseline to final MCCB composite score: nonsmokers (N=69) demonstrated a difference from placebo of 2.9 (SE=1.4) in the 10 mg group and 5.2 (SE=1.6) in the 25 mg group, whereas no differences were observed in smokers (N=113). Among the nonsmokers in the ABT-126 25 mg group (N=19), significant improvements compared with placebo occurred at final assessment for verbal learning (least squares mean difference=5.5, SE=1.9), working memory (least squares mean difference=5.4, SE=2.0), and attention/vigilance (least squares mean difference=8.7, SE=2.5). The most frequently reported adverse events for ABT-126 were dizziness, diarrhea, and fatigue (all <8% incidence). CONCLUSIONS: ABT-126 demonstrated a procognitive effect in nonsmoking subjects, particularly in verbal learning, working memory, and attention.


Assuntos
Disfunção Cognitiva/tratamento farmacológico , Disfunção Cognitiva/psicologia , Nootrópicos/uso terapêutico , Quinuclidinas/uso terapêutico , Esquizofrenia/tratamento farmacológico , Psicologia do Esquizofrênico , Tiadiazóis/uso terapêutico , Receptor Nicotínico de Acetilcolina alfa7/agonistas , Adulto , Atenção/efeitos dos fármacos , Disfunção Cognitiva/diagnóstico , Relação Dose-Resposta a Droga , Método Duplo-Cego , Feminino , Humanos , Masculino , Memória de Curto Prazo/efeitos dos fármacos , Pessoa de Meia-Idade , Testes Neuropsicológicos/estatística & dados numéricos , Nootrópicos/efeitos adversos , Psicometria , Quinuclidinas/efeitos adversos , Esquizofrenia/diagnóstico , Fumar/efeitos adversos , Tiadiazóis/efeitos adversos , Resultado do Tratamento , Aprendizagem Verbal/efeitos dos fármacos
16.
Biol Psychiatry ; 79(7): 557-67, 2016 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-26858214

RESUMO

Cannabis use has been associated with impaired cognition during acute intoxication as well as in the unintoxicated state in long-term users. However, the evidence has been mixed and contested, and no systematic reviews of the literature on neuropsychological task-based measures of cognition have been conducted in an attempt to synthesize the findings. We systematically review the empirical research published in the past decade (from January 2004 to February 2015) on acute and chronic effects of cannabis and cannabinoids and on persistence or recovery after abstinence. We summarize the findings into the major categories of the cognitive domains investigated, considering sample characteristics and associations with various cannabis use parameters. Verbal learning and memory and attention are most consistently impaired by acute and chronic exposure to cannabis. Psychomotor function is most affected during acute intoxication, with some evidence for persistence in chronic users and after cessation of use. Impaired verbal memory, attention, and some executive functions may persist after prolonged abstinence, but persistence or recovery across all cognitive domains remains underresearched. Associations between poorer performance and a range of cannabis use parameters, including a younger age of onset, are frequently reported. Little further evidence has emerged for the development of tolerance to the acutely impairing effects of cannabis. Evidence for potential protection from harmful effects by cannabidiol continues to increase but is not definitive. In light of increasing trends toward legalization of cannabis, the knowledge gained from this body of research needs to be incorporated into strategies to minimize harm.


Assuntos
Canabinoides/efeitos adversos , Cannabis/efeitos adversos , Transtornos Cognitivos/induzido quimicamente , Cognição/efeitos dos fármacos , Abuso de Maconha/psicologia , Fumar Maconha/psicologia , Atenção/efeitos dos fármacos , Canabinoides/farmacologia , Função Executiva/efeitos dos fármacos , Humanos , Memória/efeitos dos fármacos , Testes Neuropsicológicos , Desempenho Psicomotor/efeitos dos fármacos , Aprendizagem Verbal/efeitos dos fármacos
17.
Psychoneuroendocrinology ; 56: 213-25, 2015 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-25863445

RESUMO

17-Beta-estradiol (E2) facilitates long term-potentiation (LTP) and increases spine synapse density in hippocampal neurons of ovariectomized rodents. Consistent with these beneficial effects on the cellular level, E2 improves hippocampus-dependent memory. A prominent approach to study E2 effects in rodents is the inhibition of its synthesis by letrozole, which reduces LTPs and spine synapse density. In the current longitudinal functional magnetic resonance imaging (fMRI) study, we translated this approach to humans and compared the impact of E2 synthesis inhibition on memory performance and hippocampal activity in post-menopausal women taking letrozole (n = 21) to controls (n = 24). In particular, we employed various behavioral memory paradigms that allow the disentanglement of hippocampus-dependent and -independent memory. Consistent with the literature on rodents, E2 synthesis inhibition specifically impaired hippocampus-dependent memory, however, this did not apply to the same degree to all of the employed paradigms. On the neuronal level, E2 depletion tended to decrease hippocampal activity during encoding, whereas it increased activity in the anterior cingulate and the dorsolateral prefrontal cortex. We thus infer that the inhibition of E2 synthesis specifically impairs hippocampal functioning in humans, whereas the increased prefrontal activity presumably reflects a compensatory mechanism, which is already known from studies on cognitive aging and Alzheimer's disease.


Assuntos
Estradiol/biossíntese , Hipocampo/efeitos dos fármacos , Memória/efeitos dos fármacos , Inibidores da Síntese de Esteroides/farmacologia , Idoso , Anastrozol , Feminino , Giro do Cíngulo/efeitos dos fármacos , Humanos , Letrozol , Potenciação de Longa Duração/efeitos dos fármacos , Estudos Longitudinais , Imageamento por Ressonância Magnética , Memória de Curto Prazo/efeitos dos fármacos , Pessoa de Meia-Idade , Nitrilas/farmacologia , Pós-Menopausa , Córtex Pré-Frontal/efeitos dos fármacos , Desempenho Psicomotor/efeitos dos fármacos , Inquéritos e Questionários , Triazóis/farmacologia , Aprendizagem Verbal/efeitos dos fármacos , Testes de Associação de Palavras
18.
J Clin Exp Neuropsychol ; 37(2): 193-208, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-25695230

RESUMO

INTRODUCTION: This study was designed to assess sex differences in older adults (55-65 years old) in executive functions and to examine the influence of hormone therapy (HT) in postmenopausal women. METHOD: We have assessed task performance in memory, visuospatial, and executive functions in 29 women using HT, 29 women who never used HT, and 30 men. RESULTS: Men outperformed never users in task switching and updating. HT users outperformed never users in updating. HT users outperformed never users and men in visual divided attention. DISCUSSION: The present study support previous findings that sex and HT impact cognition and bring new insights on sex and HT-related differences in executive functions.


Assuntos
Transtornos Cognitivos/etiologia , Função Executiva/fisiologia , Pós-Menopausa/fisiologia , Caracteres Sexuais , Idoso , Atenção/efeitos dos fármacos , Atenção/fisiologia , Transtornos Cognitivos/tratamento farmacológico , Terapia de Reposição de Estrogênios , Estrogênios/uso terapêutico , Feminino , Humanos , Masculino , Memória/efeitos dos fármacos , Memória/fisiologia , Pessoa de Meia-Idade , Estimulação Luminosa , Pós-Menopausa/efeitos dos fármacos , Pós-Menopausa/psicologia , Processamento Espacial/efeitos dos fármacos , Processamento Espacial/fisiologia , Estatísticas não Paramétricas , Aprendizagem Verbal/efeitos dos fármacos , Aprendizagem Verbal/fisiologia
19.
Schizophr Res ; 163(1-3): 24-31, 2015 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-25248939

RESUMO

OBJECTIVES: Working memory impairment has been extensively studied in schizophrenia, but less is known about moderators of the impairment. Using the Consortium on the Genetics of Schizophrenia case-control study (COGS-2), we examined smoking status, types of antipsychotic medication, and history of substance as moderators for working memory impairment in schizophrenia. METHODS: From 5 sites, 1377 patients with schizophrenia or schizoaffective, depressed type and 1037 healthy controls completed the letter-number span (LNS) task. The LNS uses intermixed letter and digit stimuli that increase from 2 up to 8 stimuli. In the forward condition, participants repeated the letters and numbers in the order they were presented. In the reorder condition, participants repeated the digits in ascending order followed by letters in alphabetical order. RESULTS: Schizophrenia patients performed more poorly than controls, with a larger difference on reorder than forward conditions. Deficits were associated with symptoms, functional capacity, and functional outcome. Patients who smoked showed larger impairment than nonsmoking patients, primarily due to deficits on the reorder condition. The impairing association of smoking was more pronounced among patients taking first-generation than those taking second-generation antipsychotic medications. Correlations between working memory and community functioning were stronger for nonsmokers. History of substance use did not moderate working memory impairment. CONCLUSIONS: Results confirm the working memory impairment in schizophrenia, and indicate smoking status as an important moderator for these deficits. The greater impairment in smokers may reflect added burden of smoking on general health or that patients with greater deficits are more likely to smoke.


Assuntos
Memória de Curto Prazo , Esquizofrenia/complicações , Esquizofrenia/tratamento farmacológico , Psicologia do Esquizofrênico , Fumar/psicologia , Aprendizagem Verbal , Adulto , Antipsicóticos/uso terapêutico , Estudos de Casos e Controles , Endofenótipos , Família , Feminino , Humanos , Masculino , Memória de Curto Prazo/efeitos dos fármacos , Rememoração Mental/efeitos dos fármacos , Pessoa de Meia-Idade , Testes Neuropsicológicos , Transtornos Psicóticos/complicações , Transtornos Psicóticos/tratamento farmacológico , Transtornos Psicóticos/fisiopatologia , Transtornos Psicóticos/psicologia , Reconhecimento Psicológico/efeitos dos fármacos , Esquizofrenia/genética , Esquizofrenia/fisiopatologia , Fumar/fisiopatologia , Percepção da Fala/efeitos dos fármacos , Aprendizagem Verbal/efeitos dos fármacos , Adulto Jovem
20.
Psychopharmacology (Berl) ; 232(2): 343-53, 2015 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-24998257

RESUMO

RATIONALE: One of the most often reported cognitive deficits of acute cannabis administration is an impaired recall of previously learned information. OBJECTIVE: The aim of the present study was to determine whether cannabis-induced memory impairment in humans is mediated via glutamatergic or cholinergic pathways. METHODS: Fifteen occasional cannabis users participated in a double-blind, placebo-controlled, six-way cross-over study. On separate test days, subjects received combinations of pretreatment (placebo, vardenafil 20 mg or rivastigmine 3 mg) and treatment (placebo or 1,376 mg cannabis/kg body weight). Cognitive tests were administered immediately after inhalation of treatment was finished and included measures of memory (visual verbal learning task, prospective memory test, Sternberg memory test), perceptual-motor control (critical tracking task), attention (divided attention task) and motor impulsivity (stop signal task). RESULTS: The results of this study demonstrate that subjects under the influence of cannabis were impaired in all memory tasks, in critical tracking, divided attention and the stop signal task. Pretreatment with rivastigmine attenuated the effect of cannabis on delayed recall and showed a trend towards significance on immediate recall. When cannabis was given in combination with vardenafil, there were no significant interaction effects in any of the tasks. CONCLUSIONS: The present data therefore suggest that acetylcholine plays an important role in cannabis-induced memory impairment, whereas similar results for glutamate have not been demonstrated in this study.


Assuntos
Cannabis , Imidazóis/uso terapêutico , Fumar Maconha/efeitos adversos , Fumar Maconha/metabolismo , Transtornos da Memória/etiologia , Transtornos da Memória/metabolismo , Fenilcarbamatos/uso terapêutico , Piperazinas/uso terapêutico , Acetilcolina/metabolismo , Adulto , Atenção/efeitos dos fármacos , Canabinoides/administração & dosagem , Canabinoides/sangue , Cognição/efeitos dos fármacos , Estudos Cross-Over , Método Duplo-Cego , Feminino , Ácido Glutâmico/metabolismo , Humanos , Masculino , Fumar Maconha/tratamento farmacológico , Fumar Maconha/psicologia , Memória/efeitos dos fármacos , Transtornos da Memória/tratamento farmacológico , Memória de Curto Prazo/efeitos dos fármacos , Estudos Prospectivos , Rivastigmina , Sulfonas/uso terapêutico , Triazinas/uso terapêutico , Dicloridrato de Vardenafila , Aprendizagem Verbal/efeitos dos fármacos , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA